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Previous works with autumnalamide reported that Store Operated Calcium (SOC) channels were blocked through mitochondrial modulation. In the 
present paper we studied the effect of autumnalamide on ion-omycin Ca2+ fluxes. Thus, autumnalamide did not modify ionomycin-sensitive 
intracellular pools while the ionomycin-induced Ca2+ influx was blocked with similar potency whether the incubation was done before or after 
ionomycin-sensitive pools depletion. Nevertheless, autumnalamide was not able to inhibit ionomycin-induced Ca2+ influx once the membrane channels 
were activated. Moreover, the compound efficiently inhibited flufenamic acid (FFA) Ca2+ release induced in this organelle but no the next influx. Since in 
previous work the effect of autumnalamide was inhibited by cyclosporine A (CsA), structures that target this drug were studied. Therefore, the affinity of 
autumnalamide for cyclophilin D (Cyp D) was examined. The KD obtained for Cyp D- autumnalamide was 1.51 ± 1.399. Moreover, the KD for Cyp A- 
autumnalamide was calculated. The peptide had a similar order of Cyp A binding affinity than CsA (8.08 ± 1.23 and 6.85 ± 1.1 M respectively). After 
testing autumnalamide-binding capacity for Cyp A, the activity of this compound on Cyp A pathway was tested. Thus, the effect on interleukin (IL)-2 
release on activated T-lymphocytes was checked. Autumnalamide was able to reduce IL-2 levels near to T cells in resting conditions. Next, the effect 
over calcineurin and NFATc1 was also evaluated. While CsA inhibits both calcineurin and NFATc1, autumnalamide did not produce any effect. From 
these results we can con-clude that, autumnalamide targeted mitochondrion and prevent T-cells from IL-2 production through the modulation of SOC 
Ca2+ channels.
1. Introduction
Filamentous cyanobacteria of the genus Phormidium have a
worldwide distribution and present a large chemical diversity
with nearly 200 described species. The genus Phormidium forms
mats on wet soil, mud, wetted rocks, macrophytes and in stand-
ing and running waters. Up to now, several species from different
genus have been cultivated for the production of large quantities
of biomass with wide range of applications, including animal and
human nutrition, as biofertilizers in agriculture, cosmetics or with
energy purpose to produce biodiesel (Markou and Georgakakis,
2011). Nevertheless, the use of active metabolites in the pharma-
ceutical sector is less studied. In the case of cyanobacteria, the
production of toxic metabolites with therapeutic potential has
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attracted the attention of pharmacy industry (Coates et al., 2013).
Autumnalamide is a prenylated cyclic peptide obtained from the
cyanobacteria Phormidium autumnale whose chemical structure
has been recently elucidated (Fig. 1) (Audoin et al., 2014). This
specie is one of the most common of the genus Phormidium, which
colonizes stones in streams and rivers (Komárková, 2003). Initial
studies on the biological activity of this natural compound has
shown that autumnalamide is able to induce calcium influx block-
ade through store operated calcium channels (SOC channels) in
SH-SY5Y neuroblastoma cells due to an effect at the mitochondrial
level, disrupting the mitochondrial membrane potential (MMP)
and inducing the opening of mitochondrial permeability transi-
tion pore (mPTP). Moreover, the effect of autumnalamide on SOC
channels was abolished by pre-incubation with the immunosup-
pressant drug cyclosporine A (CsA), (Audoin et al., 2014). The mPTP
complex is a multiproteic structure composed by different proteins.
Among them, cyclophilin D (Cyp D) is an essential component with
a molecular weight of 22 kDa (Elrod and Molkentin, 2013; Javadov
and Kuznetsov, 2013). CsA is a cyclic 11-amino-acid peptide iso-
lated from the fungus Tolypocladium inflatum and was described as
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a potent and selective mPTP inhibitor due to Cyp D binding in the
matrix and on the inner surface of the mitochondrial membrane
(Elrod and Molkentin, 2013; Hoppert et al., 2001). Besides Cyp D
binding and mPTP opening inhibition, CsA has the ability to bind
to all Cyclophilins (Cyps) present in the cell with different affinities
due to a high degree of sequence conservation in their structure
(Wang and Heitman, 2005; Fruman et al., 1994). The Cyps protein
family structurally contain two main protein domains, a cyclophilin
(Cyp)-like domain, which is the conserved domain across all family
members and the specific domain depending on the family member
(Lee and Kim, 2010). These proteins are present in all eukaryote and
prokaryote cells like plants, fungi, bacteria, insects and human cells
with a common peptidyl-prolyl isomerase activity. That is, Cyps cat-
alyze the isomerisation of the peptide bonds from trans to cis form
at the proline residues and facilitates protein folding among other
functions (Wang and Heitman, 2005; Kofron et al., 1991; Davis et al.,
2010). The location of these proteins is very broad and can be found
in different organelles and also in the cytosol or in the extracellular
medium (Lee and Kim, 2010; Kumari et al., 2013). Our initial stud-
ies on the biological activity of autumnalamide have shown that
the compound induced the formation of mPTP. The mPTP can be
induced by different stimulus over the proteins that form this struc-
ture like Cyp D (Audoin et al., 2014). Due to this and since the effect
of autumnalamide on SOC channels was blocked by CsA, the main
objective of this work was to go into detail about the knowledge of
mechanism of action of autumnalamide.
2. Materials and methods
2.1. Chemicals and solutions
Carboxymethyl dextran (CM5) sensor chips, Hank’s Bal-
ance Solution Surfactant P20 (HBS-EP) buffer (pH 7.4, 0.01 M
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES),
0.15 M NaCl, 3 mM Ethylenediamine tetraacetic acid (EDTA),
0.005% polysorbate), amine coupling kit (1-ethyl-3- (3-
dimetylaminopropyl) carbodiimide hydrochloride (EDC) and
N-hydroxysuccinimide (NHS) and ethanolamine-HCl were sup-
plied by BiacoreAB (Uppsala, Sweden). Percoll was obtained from
Pharmacia (Uppsala, Sweden). Plastic tissue-culture dishes were
purchased from Falcon (Madrid, Spain). RPMI and Foetal calf
serum (FBS) were bought from Gibco (Glasgow, UK). The Pan T
cell Isolation Kit (human) and the monoclonal antibody to human
CD3, clone BW264/56, FITC ware purchased from Miltenyi Biotec
(Germany). Human interleukin (IL)-2 ELISA kit was obtained from
Invitrogen (Spain). Active human Cyclophilin D (Cyp D) and Active
Human Cyclophilin A (Cyp A) full-length proteins were from
Abcam (Cambridge, UK). Anti-nuclear factor of activated T cells
(NFAT) c1 mouse monoclonal antibody [AT1C3] to NFATc1 and
rabbit polyclonal anti-lamin B1 antibody were from Abcam (UK).
FURA-2AM was obtained from Molecular Probes. Polyvinylidene
fluoride (PVDF) membrane was from Millipore (Temecula, CA).
Polyacrylamide gels and molecular weight marker Precision Plus
Protein Standards Kaleidoscope was from BioRad (Barcelona,
Spain). The Protease Inhibitor Complete Tablets and Phosphatase
Inhibitor Cocktail Tablets were from Roche (Spain). Bovine serum
albumin (BSA) and CsA (purity ≥ 98.5%), Flufenamic acid (FFA),
carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP)
and the rest of Chemicals and reagents were obtained from Sigma-
Aldrich (Madrid, Spain). The strain of Phormidium autumnale was
purchased from the Culture Collection of Algae and Protozoa
(UK, CCAP1446/10). The strain was cultured and extracted as
previously described (Audoin et al., 2014). Autumnalamide was
isolated with purity higher than 95% as demonstrated by its 1H
NMR spectrum. The composition of saline solution (PBS) used for
Fig. 1. Autumnalamide chemical structure.
human T lymphocytes purification was in (mM): 137 ClNa, 8.2
Na2HPO4, 1.5 KH2PO4, 3.2 KCl and 2 EDTA. The composition of
Umbreit saline solution was in (mM): 119 NaCl, 1.2 Mg (SO4), 1.2
NaH2PO4, 22.8 NaHCO3, 5.9 KCl, 1 CaCl2 and 1 g/L Glucose. The pH
was equilibrated between 7.2-7.3. Stock solutions of drugs were
done in dimethylsulphoxide (DMSO).
2.2. Human neuroblastoma culture cells and human T
lymphocytes isolation
Neuroblastoma cell line SH-SY5Y was purchase from Ameri-
can Type Culture Collection (ATCC) Number CRL-2266. The cells
were plated in 25 cm2 flasks at a cultivation ratio of 1:10. The cells
were maintained in Eagle’s Minimum Essential Medium (EMEM)
from ATCC and F12 Medium (Invitrogen) 1:1 supplemented with
10% fetal bovine serum (FBS) (Gibco) plus 100 UI/mL penicillin and
100 g/mL streptomycin. The neuroblastoma cells were expanded
weekly using 0,05% trypsin/EDTA (1x) (Invitrogen).
Peripheral lymphocytes were isolated from human fresh hep-
arinised blood from healthy volunteers as previously described
(Alfonso et al., 2001). The blood was diluted in the same proportion
with PBS plus EDTA 2 mM previously equilibrated at room tem-
perature. 4 mL of diluted blood were placed over 3 mL of isotonic
percoll (57,5%) carefully avoiding the mixture of the two phases.
Once the tubes were prepared they were centrifuged at 3000 rpm,
25 min at room temperature. After centrifugation, different phases
were obtained and only the fraction that containing the population
of white blood cells was collected and washed three times by cen-
trifugation with PBS-EDTA at 1500 rpm, 10 min, room temperature
to remove remaining percoll. Lymphocyte purity was always higher
than 80%. T lymphocytes were purified from this population with
a human Pan T cell Isolation Kit. This is an indirect magnetic label-
ing system for the isolation of untouched T cells. T cell purity was
always higher than 95%. Assessment of cell purity was performed
by flow cytometry by using a monoclonal antibody to human CD3
labeled with FITC. Viability (>95%) was determined by trypan blue
exclusion. Pure T cells were maintained in RPMI 1640 plus 10% FBS
and plated in 24 plastic tissue-culture dishes in humidified 5% CO2
and 95% air atmosphere at 37 ◦C.
2
2.3. Measurements of cytosolic free calcium
Cells were seeded onto 18 mm glass cover slips and used
between 48 and 72 h after plating at a density of 120.000 cells/glass
cover slip. For cytosolic Ca2+ measurements, cells were washed
twice with saline solution (Umbreit) supplemented with 0.1% BSA.
Umbreit composition was (mM): NaCl 119, Mg (SO4) 1.2, NaH2PO4
1.2, NaHCO3 22.85, KCl 5.94, Glucose 0.1% and CaCl2 1. In all
assays the solutions were equilibrated with CO2 before being used,
adjusting the final pH between 7.2–7.4. The cells were loaded
with the Ca2+-sensitive fluorescent dye FURA-2 AM (0,5 M) for
6,5 min at 37 ◦C and 300 rpm. Loaded cells were washed twice with
saline solution and the cover slips were placed in a thermostatic
chamber (Life Sciences Resources, UK). Cells were viewed using
a Nikon Diphot 200 microscope equipped with epifluorescence
optics (Nikon 40X- immersion UV- Fluor objective). Addition of
drugs was made by aspiration and addition of fresh bathing solution
with the drug to the incubation chamber. Cytosolic Ca2+ levels as
FURA-2 ratio was obtained from the images collected by fluorescent
equipment, Ultra-high-speed wavelength switching illumination
system (Lambda-DG4) for excitation and Lambda 10-2 for emis-
sion from Sutter Instruments Co., USA. The Light source was a xenon
arc bulb and the different wavelengths used were chosen with fil-
ters. Cells were excited at 340 and 380 nm lights alternately and
emission was collected at 510 nm.
2.4. Viability assay
Cells were incubated with different concentrations of autum-
nalamide ranging from 0.001 to 10 M for 24 and 48 h. After
incubation, cells were washed twice with saline solution. MTT
(500 g mL−1) dissolved in saline solution was added to the 96-
well microplate for 1 h at 37 ◦C (300 rpm) in the dark. Finally the
MTT incubation media was removed and cells were washed once
before the addition of SDS at 5%. Colored formazan salt aggregates
were measured at 595 nm in a spectrophotometer plate reader.
2.5. Binding experiments: surface activation, ligand
immobilization and binding
A Biacore X SPR biosensor with Control Software and BIAeval-
uation software version 3.0 from Biacore (GE Healthcare, Uppsala,
Sweden) was used to check the binding between molecules. Sen-
sor surface activation and ligand immobilization were performed
by using HBS-EP as running buffer at a flow rate of 5 L min−1
and 25 ◦C. CM5 sensor chip were used as surface where Cyp D or
Cyp A was immobilized as ligand. The CM5 chip is a glass slide
coated with a thin layer of gold with a matrix of carboxymethylated
dextran covalently attached. The CM5 chip was activated using an
amine coupling kit. Following manufacture instructions, a mixture
(1:1, v/v) of EDC and NHS was applied for 2 min over the sensor
chip. After activation, the ligand, 100 g/mL−1 of Active human
Cyp A or Cyp D full-length protein dissolved in sodium acetate
10 mM at pH 4.5 was added. In these conditions, a typical cova-
lent binding curve was obtained. Then, the CM5 chip surface was
washed with HBS buffer and no fall in the signal was observed,
indicating the protein immobilization onto the sensor chip surface.
Finally, ethanolamine-HCl was injected to deactivate the remain-
ing active esters, remove non-covalently bound protein and avoid
non-specific binding (Sanchez et al., 2015; Alfonso et al., 2014).
Next, analytes were added to check the binding between them and
Cyp D or Cyp A. Individual binding curves for each analytes were
analyzed by determining the kinetic constant of analytes-Cyp A/D
binding, namely, the observed rate constant (Kobs), the association
rate constant (Kass), the dissociation rate constant (Kdiss), and the
kinetic equilibrium dissociation constant (KD). At equilibrium, by
definition, Kdiss/Kass = KD. The pseudo-first-order association rate
constants Kobs (s−1) were determined by using the 1:1 Langmuir
association model of BiaEvaluation software (BiaCore, Uppsala,
Sweden). Then a representation of Kobs against the corresponding
concentration of compound was done. These plots follow a linear
correlation coefficient. From the equation of this representation,
Kass, M−1 s−1, gradient of the Plot, and Kdiss, s −1, intercept of the
Plot was obtained. Within these two values, the kinetic equilib-
rium dissociation constant KD for the analyte-Cyp A/D binding was
obtained.
The duration of the sample injection was 2 min at 10 L min−1
flow rate. Next, dissociation of bounded molecules in HBS-EP buffer
flow was studied. The bounded drugs were removed from the chip
surface before the next injection by adding 1 M Glycine-HCl at
pH 2.5 for 1 min. The association phase was used to quantify the
compound-Cyp A/D interactions.
2.6. Interleukin 2 release
Human T lymphocytes at the concentration of 1 × 106 cells mL−1
were plated in 24 well plates and pre-treated for 2 h with autum-
nalamide (10 M). Then, cells were stimulated with Concanavalin
A (Con A) at 50 g/mL for 48 h to induce IL-2 release. The amount of
IL-2 released to the culture medium was evaluated using a Human
IL-2 ELISA kit.
2.7. Calcineurin phosphatase activity assay
Calcineurin phosphatase activity was used as a measure of Cyp
A activity by means of a calcineurin Phosphatase Assay Kit (Enzo
Life Sciences, Inc., Farmingdale, NY). This is a complete colorimetric
assay kit to measure calcineurin phosphatase activity. The Cyp-A-
drug complex was allowed to form for 1 h at room temperature.
1 nM of Cyp A and different concentrations of drugs were employed
dissolved in deionised water. After 1 h, recombinant calmodulin
(0.25 M) and recombinant calcineurin (40 units per well) were
added to the complex formed between Cyp A and Autumnalamide
or CsA. The complex was incubated for 30 min. Next; RII phospho-
peptide substrate was added at a final concentration of 0.15 mM
allowing the development of the reaction for 1 h at room tempera-
ture. Then 100 L of development reagent was added and incubated
for 20 min at room temperature. Finally, the A620 of the 96-well
plate samples was measured using Multi-Mode Microplate Reader
Synergy TM 4 equipment from Biotek (Winooski, VT, USA).
2.8. Western blotting
Cells were incubated first with autumnalamide or CsA for 2 h
after which Con A (50 g/mL) was added for 48 h. After incu-
bation, T cells were centrifuged and washed twice with ice-cold
saline solution (Umbreit) at 1500 rpm, 5 min and 4 ◦C. Then, the
pellet was resuspended in 50 L of hypotonic lysis buffer solu-
tion to extract cytosolic proteins for 15 min with the following
composition mM: 20 Tris-HCl, 10 NaCl and 3 MgCl2, 10X phos-
phatase inhibitors and 7X protease inhibitor. Cells were pelleted
at 3000 rpm, 10 min at 4 ◦C to remove the cytosolic protein frac-
tion. The supernatant was collected and the pellet obtained was
resuspended in 30 L of nuclear lysis buffer composed by: 100 mM
Tris, 2 mM NaVO4, 10 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM NaF,
20 mM Na4P2O7, 1% Triton-X-100, 10% Glycerol, 0,1% SDS and 0,5%
Deoxychocolate Sodium containing 1 mM PMSF and 10X protease
inhibitor cocktail for 30 min vortexing every 10 min. Samples were
then centrifuged at 14000g at 4 ◦C for 30 min. The supernatants
of interest were collected as protein nuclear fraction. The deter-
mination of protein concentration was done using Direct Detect
(Millipore) using bovine serum albumin (BSA) as standard protein.
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Fig. 2. Effects of autumnalamide and ionomycin cytosolic Ca2+ profile in SH-SY5Y
neuroblastoma cells. A. First arrow indicates the addition of 2 M ionomycin.
Second arrow shows addition of 10 M of autumnalamide. The third arrow
indicates the addition of Ca2+ 1 mM to the bath solution B. Cytosolic Ca2+ profile
in cells first pre-incubated with 10 M autumnalamide (first arrow) followed
Samples of cell lysates containing 10 g of nuclear fraction of total
protein were used for electrophoresis. Samples for electrophore-
sis were dissolved in a 15–20% polyacrylmide gel and blotted to
PVDF membrane by reduced SDS-PAGE. To determine the protein
size and also to monitor the progress of the electrophoresis run,
Precision Plus Protein Standards Kaleidoscope molecular weight
marker was used. Then, membranes were blocked with 0,5% BSA
in washing buffer (PBS + 0.1% Tween) and incubated 10 min with
primary anti-NFATc1 (1:1000). After three washes with washing
buffer (PBS + 0.1% Tween 20), membranes were incubated with sec-
ondary anti-Mouse IgG conjugated with horseradish peroxidase.
The immunoreactive bands were detected using the Supersignal
West Pico or Supersignal West Femto Maximum Sensitivity Sub-
strate (Pierce) and the Diversity GeneSnap software (Syngene).
NFATc1 signal was normalized using Lamin B1 (1:1000).
2.9. Statistical analysis
All experiments were carried out by duplicate a minimum of
three times. Results were analyzed by using one-way analysis of
variance ANOVA with Dunnett’s post hoc analysis. p values < 0.05
were considered statistically significant. All results were expressed
as the mean ± SEM of 3 or more experiments.
3. Results
Considering the results obtained in a previous work, autum-
nalamide was able to completely inhibit SOC channels by its effect
over mitochondrion (Audoin et al., 2014). Therefore, several addi-
tional calcium (Ca2+) experiments were carried out in order to
clarify the effect of autumnalamide on Ca2+ fluxes different from
SOC. To do this, the effect of autumnalamide on ionomycin Ca2+
fluxes was studied. Ionomycin is a Ca2+ ionophore that induces
intracellular pools depletion and allows Ca2+ entrance from the
extracellular medium (Morgan and Jacob, 1994). Thus, autum-
nalamide was added in a Ca2+-free medium after ionomycin pools
depletion, and a significant cytosolic Ca2+ influx reduction was
observed after ion addition (Fig. 2A). In the same way, when the
compound was incubated in a Ca2+-free medium before ionomycin
addition, no modification on intracellular stores was observed nei-
ther on ionomycin-sensitive pools depletion. Nevertheless, once
Ca2+ ion was restored, a significant ion-influx inhibition was
obtained comparing to ionomycin (Fig. 2B). Moreover, autum-
nalamide did not inhibit the ion entrance once the influx is activated
(Fig. 2C). Thus, autumnalamide did not affect intracellular pools
modulated by ionomycin; nevertheless cytosolic Ca2+ entrance was
reduced a 30% when the incubation with autumnalamide was done
after or before ionomycin-sensitive pools depletion. Therefore, as
it was reported, the compound inhibits SOC entrance.
In order to confirm if autumnalamide inhibits other Ca2+ influx
different from SOC, flufenamic acid (FFA) was employed. FFA is a
non-steroidal drug that acts inducing Ca2+ release from the mito-
chondrion in a Ca2+ free medium (Jiang et al., 2012; Damsker et al.,
2009; Zeng et al., 2012). Thus, when FFA was incubated in the
absence of Ca2+, a significant Ca2+ release from internal stores was
induced. In addition, when Ca2+ was added to the medium an ion
influx was observed (Fig. 3A). Nevertheless, when autumnalamide
was incubated before the FFA addition, the Ca2+ release from mito-
chondrion was significantly inhibited, besides after addition of Ca2+
the ion reached similar levels than FFA (Fig. 3A). Therefore, the
by ionomycin 2 M (second arrow). The third arrow indicates 1 mM of Ca2+ addition
to the bath solution. C. The first arrow shows the ionomycin addition. The second
arrow shows the Ca2+ addition to the medium and the third the addition of 10 M of
autumnalamide. The experiments were performed in duplicate. The results of each
replica are mean of 20 cells. Mean ± SEM of three independent experiments.
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Fig. 3. Effect of FCCP or autumnalamide and FFA on cytosolic Ca2+ profile in SH-
SY5Y neuroblastoma cells. A. First arrow indicates autumnalamide addition and the
second arrow the FFA addition. The third arrow indicates the addition of Ca2+. B. The
FCCP addition to the medium (first arrow) prior to FFA addition (second arrow). The
third arrow indicates the addition of the ion to the Ca2+-free bathed solution. The
experiments were performed in duplicate. The results of each replica are mean of
20 cells. Mean ± SEM of three independent experiments.
compound does not affect mitochondrial Ca2+ influx, however the
release of the ion from this organelle was largely reduced. In order
to know the effect of other mitochondrial uncouplers on FFA, FCCP
was employed (Ma et al., 2012). As shown in Fig. 3B, FCCP produced
a small increase in Ca2+ levels; and the following addition of FFA
did not induce a Ca2+ release. Thus, after the ion addition to the
bath solution, a similar Ca2+ influx as FFA control was observed.
Therefore, as in the case of autumnalamide, the prior incuba-
tion with FCCP inhibited the Ca2+ release induced by FFA without
affecting the next Ca2+ influx. Summarizing the results described
above, both, FCCP and autumnalamide were able to decrease the
release of Ca2+ from mitochondrion induced by FFA; nevertheless
the cytosolic Ca2+ entrance was not blocked. In addition, autum-
nalamide inhibited cytosolic Ca2+ influx induced by the ionophore
while ionomycin-sensitive intracellular pools were not modified.
Therefore, autumnalamide targeted mitochondrion without induc-
ing Ca2+ release from this organelle but inhibiting SOC influx.
In order to explain the effect of autumnalamide on Ca2+ handling
and since in a previous work it was observed the effect of autum-
nalamide inhibiting Ca2+ influx, which was reverted by CsA (Audoin
et al., 2014), the structures that this drug targets were studied. With
this purpose, the highly sensitive biosensor Biacore X was used to
determine the binding between mitochondrial Cyp D, used as lig-
and, attached to the sensor surface and using autumnalamide as
ligate. First, CsA was used as control of binding for the immobilized
Cyp D. As Fig. 4A shows, when different concentrations of CsA (5,
10, 20 and 40 M) were added over the immobilized Cyp D, typical
association curves profiles were obtained. In the presence of 5 M
CsA the signal was 10.05 RU, while in the presence of 40 M of
CsA the response reached 31.8 RU. Individual binding curves from
Fig. 4A were analyzed as described in the material and methods sec-
tion. Kobs for each concentration of CsA were obtained. When Kobs
were represented against each CsA concentration, (Fig. 4B), a lin-
ear regression with a correlation coefficient of r = 0.97985 for Cyp D
was obtained. From this representation, Kass, M−1 s−1, slope, Kdiss,
s −1, and Y-intercept, were obtained. Within these two values, the
kinetic equilibrium dissociation constant KD (Y-intercept/slope) for
the CsA-Cyp D association was obtained. The value of this constant
was 4.5 × 10−6 ± 3.05 × 10−6 M for the CsA-Cyp D binding assay
(Fig. 4B). After setting up these conditions the binding of Cyp D and
autumnalamide was next studied. In this case, different concentra-
tions of autumnalamide (30, 50, 70 and 100 M) were dissolved
in HBS-EP buffer and added onto the previously immobilized Cyp
D. Thus, as Fig. 4C shows, association curves for the binding of
autumnalamide with Cyp D were obtained with responses rang-
ing from 10 RU at the lowest autumnalamide concentration to 220
RU in the presence of 100 M of the compound. As in the case of
CsA, the interaction between autumnalamide and Cyp D follows a
pseudo-first order kinetic where Kobs was calculated. When each
Kobs was represented against the corresponding concentration of
autumnalamide from Fig. 4C, linear regression plots with a cor-
relation coefficient of r = 0.98, for the binding of autumnalamide
to Cyp D were obtained. From these representations the kinetic
equilibrium constant for the binding of autumnalamide to Cyp D
was calculated. In the case of the Cyp D-autumnalamide binding,
a KD = 1.51 ± 1.399 M (Fig. 4D) was obtained. Due to Cyps share
a common region domain and since autumnalamide showed good
binding affinity for Cyp D, the effect of this compound over Cyp
A, another important immunophilin, was also evaluated. Straight-
away, the same procedure was followed for Cyp A immobilization
over a CM5 chip as described in Material and Methods. Thus, when
different concentrations of CsA were added over the immobilized
Cyp A, typical association curves were obtained. In the presence
of 5 M CsA the signal was 17.54 RU, while in the presence of
40 M of CsA the response reached 55.45 RU (Fig. 5A). In this case, a
KD for CsA-Cyp A was 6.83 × 10−6 ± 1.1 × 10−6 M (Fig. 5B). In the
same way, different concentrations of autumnalamide were dis-
solved in HBS-EP buffer and added onto the immobilized Cyp A.
Thus, as Fig. 5C shows, association curves for the binding of autum-
nalamide with Cyp A were obtained with responses ranging from
34.11RU at the lowest concentration to 102.5 RU at the highest con-
centration of autumnalamide. From the association curves a KD of
8.08 ± 1.23 M was obtained (Fig. 5D). So far the results obtained
here indicated that autumnalamide showed higher affinity for Cyp
D than CsA and also a good affinity for Cyp A, although slightly
smaller than that of CsA.
Hence, autumnalamide showed Cyp A binding, and also acts
by inhibiting SOC influx; both targets are related with the mod-
ulation of interleukins (ILs) (Sweeney et al., 2009; Djuric et al.,
2000), we then tested the effect of autumnalamide on IL-2 pro-
duction in human T lymphocytes. In previous work the effect of
autumnalamide in SH-SY5Y cell viability was checked for 1 h, and
the compound produced a 42% of decrease in cell viability at the
concentration of 25 M (the highest concentration tested) (Audoin
et al., 2014). In order to develop experiments with prolonged expo-
sure times and in different cellular model, it was necessary to check
cell toxicity of autumnalamide. To do this, different concentrations
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Fig. 4. CsA/autumnalamide association curves and ligand binding analysis. A. Cyp D-CsA association: association curves after addition of different amounts of CsA to
immobilized Cyp D. Different CsA concentrations were injected using HBS-EP as running buffer and a flow rate of 10 g mL−1. The association curves were obtained after
subtraction of their respective solvent control. B. Analysis of ligand binding: kinetic plot of apparent association rate constant Kobs (s−1) obtained from plot A (calculated
by BiaEvaluation software) versus CsA concentration. C. Cyp D-autumnalamide association: association curves after addition of different amounts of autumnalamide to
immobilized Cyp D. Different autumnalamide concentrations were injected using HBS-EP as running buffer and a flow rate of 10 g mL−1. The association curves were
obtained after subtraction of their respective solvent control. D. Analysis of ligand binding: kinetic plot of apparent association rate constant Kobs (s−1) obtained from plot C
(calculated by BiaEvaluation software) versus autumnalamide concentration. Representative experiment of n = 3.
ranges of autumnalamide were tested for 24 and 48 h in human
T lymphocytes. As Fig. 6 shows, the concentrations tested for the
two exposure times did not produced any changes on cell viability.
Once again, the concentration of 10 M was selected to develop the
current experiments at 48 h.
To develop IL-2 experiments, a control of human T lymphocytes
was treated with Con A alone, to induce IL-2 release, or in combi-
nation with autumnalamide. After 48 h of incubation, IL-2 release
in the culture medium was measured. As Fig. 7 shows, the stim-
ulation of human T lymphocytes with Con A for 48 h efficiently
induces IL-2 production comparing with non-stimulated control
cells from 47.72 ± 1.58 pg mL−1 to 742,77 ± 152.23 pg mL−1 respec-
tively (p ≤ 0.001). In this conditions, when T lymphocytes were
pre-incubated for 2 h with 10 M autumnalamide, before stimula-
tion with ConA for 48 h, a reduction from 742,77 ± 152.23 pg mL−1
to 111.61 ± 3.4 pg mL−1 (p ≤ 0.01). The well-known IL-2 inhibitor
CsA was used as positive control of IL-2 inhibition. Thus, when cells
were pre-incubated with CsA 0.2 M for 2 h before Con A stimu-
lation, IL-2 production was significantly reduced to control values
146.25 ± 111.34 pg mL−1 (p ≤ 0.01). From these results we conclude
that both compounds suppressed IL-2 release from human acti-
vated T lymphocytes with a similar efficacy.
In view of these results two additional experiments were per-
formed to evaluate the mechanisms underlying the effects of
autumnalamide in IL-2 blockade. Some compounds, as in the case
of CsA, act docking calcineurin phosphatase activity over NFATc1
and the next IL-2 induction due to the binary complex formed with
Cyp A (Randak et al., 1990). Therefore, in view of the binding of
autumnalamide to Cyp A, the ability of autumnalamide to inhibit
calcineurin phosphatase activity was next compared. In this case,
a compound concentration close to the calculated KD was used.
As Fig. 8 shows, when Cyp A was incubated in the presence of
6 M CsA a significant reduction in calcineurin phosphatase activity
of 28.33 ± 3.07% (p ≤ 0.01) was observed. In the same way, in the
presence of 10 M of autumnalamide a significant 18.87 ± 2.21%
(p ≤ 0.001) reduction was observed over calcineurin phosphatase
activity.
It is known that T lymphocyte stimulation with Con A induce
a cytosolic Ca2+ increase (Smith-Garvin et al., 2009). As a con-
sequence, Cyp A forms a complex with calcineurin that binds to
and dephosphorylates cytosolic NFATc1. The dephosphorylation of
the nuclear factor leads to the translocation to the nucleus. The
increase in the nuclear expression of NFATc1 in a transcription-
ally active form leads to the increase of IL-2 production (Liu, 2009;
Xiong et al., 2013). Therefore, the nuclear expression of NFATc1
in activated human peripheral T lymphocytes in the presence of
autumnalamide was next checked and compared with the effect of
CsA in the same condition. Representative western blot bands for
these results are shown in Fig. 9A. As shown in Fig. 9B, the quantifi-
cation of western blot band intensities in each condition showed
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Fig. 5. CsA/atumnalamide association to immobilized Cyp A and ligand binding analysis. A. Cyp A-CsA association: association curves after addition of different amounts of
CsA to immobilized Cyp A. Different CsA concentrations were injected using HBS-EP as running buffer and a flow rate of 10 g mL−1. The association curves were obtained
after subtraction of their respective solvent control. B. Analysis of ligand binding: kinetic plot of apparent association rate constant Kobs (s−1) obtained from plot A (calculated
by BiaEvaluation software) versus CsA concentration. C. Cyp A-autumnalamide association: association curves after addition of different amounts of autumnalamide to
immobilized Cyp A. Different autumnalamide concentrations were injected using HBS-EP as running buffer and a flow rate of 10 g mL−1. The association curves were
obtained after subtraction of their respective solvent control. D. Analysis of ligand binding: kinetic plot of apparent association rate constant Kobs (s−1) obtained from plot C
(calculated by BiaEvaluation software) versus autumnalamide concentration. Representative experiment of n = 3.
that when cells were stimulated with Con A for 48 h nuclear band
intensity of NFATc1 exhibited a 67.21 ± 0.12% (p ≤ 0.01) increase
comparing with T cells in resting conditions. Pre-incubation of the
cells with CsA before activation decreased NFATc1 band inten-
sity close to control values, in agreement with previously reported
results (Ishikawa et al., 2003). However, autumnalamide did not
significantly reduce the increase in nuclear NFATc1 in activated
human T lymphocytes that reach higher levels than Con A treated
cells.
Altogether, the results presented here indicate that, autum-
nalamide does not modify ionomycin-sensitive intracellular Ca2+
pools, besides confirm that the compound inhibits the SOC chan-
nels. Moreover, it binds to mitochondrion Cyp D, presents binding
affinity for Cyp A and inhibits calcineurin and human IL-2 pro-
duction in activated T lymphocytes but, unlike CsA, it lacks of an
inhibitory effect over NFATc1.
4. Discussion
The structure of the prenylated cyclic peptide named autum-
nalamide was recently identified and the same paper reported
the only available data on the compound, indicating that
autumnalamide alters mitochondrial membrane potential in neu-
roblastoma cells and also induces the mPTP opening (Audoin et al.,
2014). The opening of this structure can be induced by different
substances that do not necessarily target the proteins that form the
mPTP structure (Tornero et al., 2002). There are many molecules
from the own organism that act as inducers of mPTP, such as -
Amyloid (A) protein, as well as molecules with natural origin
like mastoparan from the venom of Vespula lewisii; honokiol from
Magnolia spp. or molecules from synthetic sources like MT-21. Nev-
ertheless, almost no molecule acts targeting directly Cyp D, both
for blocking or inducing the formation of mPTP. In the case of
A protein, it induces the production of Reactive Oxygen Species
(ROS), mastoparan forms channels in the mitochondria and MT-21
directly induces the release of cytochrome c from mitochondria. All
these factors lead to the opening of mPTP (Watabe et al., 2000; Ding
and Nam Ong, 2003; Du and Yan, 2010; Arora et al., 2012). Thus,
with the exception of honokiol, none of these compounds induces
the mPTP opening directly by binding to a specific component of
the multiproteic complex, as we observed with autumnalamide in
the present paper. On the other hand, Ca2+ experiments reveal that
autumnalamide neither modify ionomycin-sensitive intracellular
Ca2+ pools, nor the ionomycin Ca2+ entrance through SOC channels
once the influx is activated. Nevertheless, the Ca2+ profiles obtained
from the present study show that the FFA-induced Ca2+ release
in SH-SY5Y is inhibited by pre-treatment with FCCP, which col-
lapse the mitochondrial membrane potential that normally drives
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Fig. 6. Effect of autumnalamide over T lymphocytes cell viability. T lymphocytes
cells were incubated for 24 and 48 h with autumnalamide at the concentration
range from 1 nM to 10 M. Bar columns represent the different concentrations for
each times. Effect on cell viability tested by MTT test. Data are mean ± SEM of 3
independent experiments. Data are mean ± SEM of 3 independent experiments.
Fig. 7. Effect of CsA or autumnalamide on IL-2 production in human T lymphocytes
stimulated with Con A. Human T lymphocytes were pre-treated for two hours with
CsA (0.2 M) or autumnalamide (10 M) and then with Con A (50 g mL-1) for 48 h.
Mean ± SEM of three experiments. All values are shown in percentage to the Con
A treated cells. **Significant differences between autumnalamide or CsA treated
cells with respect to cells treated with Con A (p < 0.01). # Significant differences
between Con A treated cells and control (p < 0.001). Mean ± SEM of 3 independent
experiments.
the Ca2+ into the mitochondrion (Collins et al., 2000). The effect
of autumnalamide over FFA may be achieved through either a
protonophore-like effect, similar to FCCP, or the induction of the
mPTP, as previously described (Audoin et al., 2014). Thus, in the
case of FCCP in SH-SY5Y cells, the uncoupling of the mitochondrial
transport chain produced in mitochondria, substantially inhibits
Ca2+ release induced by FFA probably because both FCCP and FFA
act by disrupting mitochondrial membrane potential, and one drug
blocks the effect of the other (Chi et al., 2011). Moreover, CsA abol-
ished the effect of autumnalamide efficiently in comparison with
FCCP on SOC Ca2+ influx (Audoin et al., 2014). In accordance with
these previous results and due to the effect observed over mPTP
by autumnalamide, the binding of the prenylated cyclic peptide
from the cyanobacterium Phormidium autumnale was tested on Cyp
D, an essential component of the mPTP. Biosensor data analysis
indicates that the compound binds with good affinity to mitochon-
drial Cyp D. Autumnalamide almost shows 3 times more affinity
for mitochondrial Cyp D than CsA. Moreover, due to the findings
Fig. 8. Effect of autumnalamide or CsA on Ca2+/calmodulin-dependent on Phos-
phatase Activity of Calcineurin. Phosphatase activity of calcineurin determined after
pre-incubation with Cyp A or Cyp A + CsA (6 M)/autumnalamide (10 M). All val-
ues are shown in percentage with respect to Cyp A control. **Significant differences
between Cyp A control and Cyp A + CsA (p ≤ 0.01). ***Significant differences between
Cyp A control and Cyp A + autumnalamide (p ≤ 0.001). Data are mean ± SEM of 3
independent experiments.
Fig. 9. Effect of CsA or autumnalamide over NFATc1 nuclear levels in human T lym-
phocytes activated with Con A. A. NFATc1 levels were studied as nuclear fraction
after 48 h incubation with compounds. Human T lymphocytes were pre-treated for
2 h with CsA (0.2 M) or autumnalamide (10 M) and afterward incubated with Con
A (50 g mL−1) for 48 h. A. Representative image of one experiment. B. Mean of the
ratio of the nuclear NFATc1/lamin B1 band intensity. All results are presented as
the percentage of NFATc1 in the nucleus. ##Significant differences with respect to
control cells (p ≤ 0.01). **Significant differences with respect to Con A treated cells
(p < 0.01). Data are mean ± SEM of three experiments.
observed by SPR and taking into account the results observed on
mPTP besides the uncoupling effect (Audoin et al., 2014), this effect
could be related with the interaction between autumnalamide and
mitochondrial Cyp D in a more specific way than in the case of
FCCP or FFA that is produced mainly by the disruption of membrane
potential. Cyps share a common domain; therefore compounds that
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bind to one of this protein family usually show binding affinity
for other Cyps as CsA display (Kumari et al., 2013). Thus, autum-
nalamide also shows, as CsA, Cyp A binding affinity. This cytosolic
protein plays a central pathway of many physiological and patho-
logical processes in the cells such as inflammation, cardiovascular
diseases, immunomodulation or sepsis among others (Nigro et al.,
2013). In the case of CsA, once the complex between Cyp A- CsA is
formed, calcineurin phosphatase activity is blocked and the translo-
cation of NFAT to the nucleus is avoided, inhibiting the transcription
activity over genes that encodes for IL-2 (Fruman et al., 1992).
Autumnalamide reduces calcineurin phosphatase activity, while
NFAT was not reduced after the binding to Cyp A, nevertheless,
autumnalamide, as CsA, reduces IL-2 production in T lymphocytes.
While CsA exerts its effect through the docking of calcineurin
(Naesens et al., 2009), the inhibition of IL-2 produced by autum-
nalamide probably occurs partially by a calcineurin-independent
pathway since the nuclear entry of the NFATc1 is closely linked to its
dephosphorilation and the nuclear levels of this transcription fac-
tor are not blocked after autumnalamide treatment. Molecules that
inhibit CRAC channels are also expected to reduce IL-2 production
(Sweeney et al., 2009; Djuric et al., 2000). As FFA or BTP2, two com-
pounds that modulate SOC channels, act by reducing the production
of this IL in white blood cells, being Ca2+ an essential signal for
its production (Kankaanranta et al., 1996; Cardenas and Heitman,
1995). In the case of autumnalamide, the indirect blockade pro-
duced on SOC channels, the main Ca2+ entrance in T cells, due to
the effects that produce in mitochondrion, could explain the effect
over IL-2 inhibition, although it does not block NFAT transloca-
tion. Then, other transcription factors or mitogen-activated protein
kinases (MAPK) could be related with the modulation of inter-
leukins (ILs) by autumnalamide where the restriction of cytosolic
Ca2+ induced by the compound may be essential (Audoin et al.,
2014; Cardenas and Heitman, 1995; Kar et al., 2011). On the other
hand, autumnalamide can be a useful tool to study molecules that
targeted Cyp D, other applications could be attributed to autum-
nalamide due to the binding to Cyp A. This effort mainly led to
the development of compounds with immunosuppressive or anti-
inflammatory effects.
As a conclusion, we have a drug that has good affinity for two
important immunophilins engaged in many diseases and produces
an effective blockade on IL-2 production and low toxicity. Due to
the multi-functional properties of Cyp A and the functions where it
is involved, such as protein folding, trafficking, assembly or cell sig-
naling, autumnalamide could open a new window to improve the
treatment of many diseases where Cyp A is a key player (Nigro et al.,
2013). With respect to Cyp D, the fact that mPTP is a process regu-
lated by a wide type of stimulus, it makes this multiproteic complex
an ideal pharmacological target implicated in multiple processes,
where autumnalamide directly binds to (Tornero et al., 2002).
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